I’ve done my part to hold Fairley, Baade and Thomas to account. I reported Starpharma to the ASX twice last year. Apparently there was nothing to see. On this forum I’ve raised all the instances where I believed IMO, that JF and co have not delivered after inferring to investors that major developments were imminent. I’ve written multiple times to Starpharma Investor Relations only to usually receive no reply, or a fluff reply. I’ve urged Hotcopper members to DYOR and not be influenced by the usual blatant rampers. I also encouraged others to make their vote count at the AGM. I sold my shares over a month ago. I will likely buy SPL again for a brief sugar hit trade after a suitable announcement but I will never hold long term again. Personally I do not trust a single word that is prepared by CEO Jackie Fairley, CFO Nigel Baade and then authorised by Chairman Rob Thomas. Period. GLTAH
SPL Price at posting:
$1.14 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)